Finance

Lists
9UA:FRA
NervGen Pharma Corp
€1.95
+8.94%
(+0.16) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 9UA...
Open
€1.89
High
€1.95
Low
€1.89
Mkt. cap
250.53M
Avg. vol.
775.00
Volume
0.00
52-wk high
€5.00
52-wk low
€1.27
No. of employees
10
Open
€1.89
High
€1.95
Low
€1.89
Mkt. cap
250.53M
Avg. vol.
775.00
Volume
0.00
52-wk high
€5.00
52-wk low
€1.27
No. of employees
10
News stories
From web sources and news partners
About NervGen Pharma Corp
CEO-
Employees10
Founded2017
HeadquartersVancouver, British Columbia, Canada
SectorPharmaceutical industry
Websitenervgen.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4.44M
3.60M
4.86M
7.89M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.73M
2.80M
2.67M
4.31M
Operating expense
6.17M
6.40M
7.53M
12.20M
Total operating expenses
6.17M
6.40M
7.53M
12.20M
Operating income
-6.17M
-6.40M
-7.53M
-12.20M
Other non operating income
1.98M
-20.24M
5.72M
-19.35M
EBT including unusual items
-4.16M
-26.91M
-1.68M
-29.22M
EBT excluding unusual items
-4.16M
-26.91M
-1.68M
-29.22M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4.16M
-26.91M
-1.68M
-29.22M
Net profit margin
-
-
-
-
Earnings per share
-0.06
-
-
-
Interest and investment income
77.07K
61.68K
104.07K
180.45K
Interest expense
-
-
-
-
Net interest expenses
77.07K
61.68K
104.07K
180.45K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.16M
-6.39M
-7.52M
-12.18M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps